UNC PY2s Create Guide to Pharmaceutical Industry for Pharm.D. Students

April 1, 2019

When Jeff Pike explains why he chose pharmacy school, he points to the two sides of pharmacy he finds most engaging. First, there’s the science. Pike is fascinated by the high level of science pharmacy demands — particularly the elegance with which drugs target certain receptors in the body. Then, there’s the communication skills Pharm.D. students must learn to use. A successful pharmacist must be able to convey advanced medical information to doctors on the one hand, and simplify the information for patients on the other. “There’s this combination of scientific expertise, coupled with really high level of communication,” said … Continued


Pharm.D. Students Compete in AMCP P&T Local Competition

February 6, 2019

After months of preparation, three teams of Pharm.D. students faced off for the chance to compete for a third straight national championship. Three student teams, hoping to represent the UNC Eshelman School of Pharmacy at the Academy of Managed Care Pharmacy Foundation’s Pharmacy and Therapeutics Competition, presented at the School’s P&T Local Competition on Jan 26. To determine which team will participate in the national AMCP competition, the teams presented clinical and economic recommendations for Radius Health’s TYMLOS® (abaloparatide), a promising but expensive new parathyroid hormone analogue for the treatment of severe osteoporosis in postemenopausal women. The winning team of … Continued


CMO Summit Takes On Medication Mismanagement

January 22, 2019

The UNC Eshelman School of Pharmacy and the School’s Center for Medication Optimization brought together leaders from across the health care industry to highlight the multi-billion dollar problem of medication mismanagement and develop collaborative medication optimization strategies that aim to transform health care. More than half of the U.S. population takes multiple medications daily to help treat one or more chronic conditions, such as hypertension and diabetes. Other serious conditions, like cancer and HIV, have extremely complex regimens that must be coordinated. And when these medication regimens are mismanaged by health care providers and patients, it can lead to unnecessary medical … Continued


$65 Million Pinnacle Hill Fund Opens for RFPs

December 12, 2018

Pinnacle Hill, UNC-Chapel Hill’s new partnership with Deerfield Management, offers faculty at the UNC Eshelman School of Pharmacy an opportunity to pursue funding to advance novel drug therapy projects. All UNC investigators are encouraged to submit therapeutic preproposals to Pinnacle Hill for potential funding, which may support studies to reach the IND-ready stage. Mark your calendar for these important dates: Monday, Jan. 7: Preproposal RFP opens Wednesday, Feb. 6: Preproposal RFP closes Which therapeutic areas will the RFP cover? This RFP is directed toward any and all therapeutic areas that address unmet medical needs. It includes any type of drug … Continued


Anselmo Authors Review of Biologics Delivery Strategies

December 5, 2018

Biological pharmaceutical products are becoming increasingly utilized in the clinic, setting off corresponding changes in the development of drug delivery technologies, according to a new paper from the UNC Eshelman School of Pharmacy. The review, written by Aaron Anselmo, Ph.D., and collaborators, was published in Nature Reviews Drug Discovery on Nov. 30. Anselmo is an assistant professor in the School’s Division of Pharmacoengineering and Molecular Pharmaceutics. His paper, “Non-Invasive Delivery Strategies for Biologics,” assesses the academic and industry efforts to develop new delivery strategies for biologics. Biologics represent the cutting edge of biomedical research, and have a much broader range … Continued


UNC-Chapel Hill and Deerfield Management Launch Drug Discovery Company

November 1, 2018

The University of North Carolina at Chapel Hill and Deerfield Management have entered into a partnership to create Pinnacle Hill, LLC., a company seeking to discover new medicines to address the significant unmet medical needs of our times. Deerfield has committed $65 million of targeted funding and to provide drug development expertise in support of promising new drug research across a wide range of therapeutic areas. “This is a very exciting new partnership between UNC-Chapel Hill and Deerfield Management. In creating a new company, Pinnacle Hill, we are bringing together the best of academia and industry to accelerate innovative drug research,” said … Continued


iNClusive STEM Pitch Summit Highlights Female, Minority Entrepreneurs

October 29, 2018

Minority and female entrepreneurs gathered at the Rizzo Center on October 11 to participate in the iNClusive STEM Innovation Pitch Summit. The event, co-hosted by the UNC Eshelman School of Pharmacy and the UNC School of Law, allowed entrepreneurs from underrepresented and disadvantaged backgrounds to showcase and pitch their innovations and businesses for the opportunity to receive funding. The event was open to women, African-Americans, Hispanics and American Indians in STEM fields. Event organizer and assistant professor Anita Jackson, M.D., M.P.H., said the event supported the School and University mission to support underrepresented groups. “UNC’s first iNClusive STEM Innovation Pitch … Continued


Third Carolina Nanoformulation Workshop Shares Discoveries in Nanomedicine

April 25, 2018

From March 12 to 16, scientists from industry and academia came together at the UNC Eshelman School of Pharmacy to learn about the latest advances in nanomedicine and to get hands-on experience with advanced nanoformulations at the third annual Carolina Nanoformulation Workshop. The workshop is a unique blend of classroom and hands-on training that stresses interaction and participation. The 2018 edition featured three days of seminars presented by 21 speakers followed by two days of practical experience in the laboratories of the School’s Center for Nanotechnology in Drug Delivery. Twenty-seven participants have attended the workshop, with each experiencing a unique … Continued


UNC Catalyst Hosts NIH/NCATS Assay Guidance Workshop

October 25, 2017

The UNC Catalyst for Rare Diseases, together with Promega, sponsored an NIH/NCATS assay guidance workshop for high-throughput screening and lead discovery on Monday, October 23. Forty-nine scientists from academia and the pharmaceutical and biotechnology industries registered to attend. The workshop was held at the University of North Carolina at Chapel Hill’s Carolina Club and was followed by an evening reception. “The workshop proved to be an invaluable opportunity to learn about the current state of the art and best practices in the areas of assay development, high throughput screening and lead optimization,” said Dave Morris, Ph.D., interim director of UNC … Continued


$10 Billion in UNC Startup Revenue Delivers Economic Boost to NC

August 17, 2017

Falcon Therapeutics, a company spun out of Assistant Professor Shawn’s Hingtgen’s work treating brain cancer, is one of the ventures contributing to a rise in the economic value of startups connected with the University of North Carolina at Chapel Hill, according to a biannual report on Carolina’s commercial and social ventures. Falcon Therapeutics is advancing a new approach using tumor-homing stems cells to treat glioblastoma cancer, the most common form of primary brain cancer and also one of the deadliest. The company recently raised $700,000 in a private equity stock offering, according to a Securities and Exchange Commission filing. It … Continued